DGD Research - Leading the search for better health.
Current Research - Information on trials & testing
Study Opportunities - Learn how you can get involved
Healthy Living - Latest news on staying healthy
About DGD Research - Who we are and why we care
 Healthy Living

Phase II-IV: West Side

Diabetes Type II Currently taking Metformin

  Study Medication:   Oral Pill
  Inclusion Criteria:   Males and Females;  Age 18-78
  Study Length:   approximately 28 weeks
  Compensation:   Contact study center for information

Diabetes Type II 

  Study Medication:   Oral Pill
  Inclusion Criteria:   Males and Females;  Age 18-77
  Study Length:   25 months
  Additional Info:   Long Draws;  Oral Glucose Tolerance Tests performed during study
  Compensation:   contact study center for information

Diabetes Type II Newly Diagnosed

  Study Medication:   Oral Pill
  Inclusion Criteria:   Males and Females;  Age 30-80
  Study Length:   approximately 10 months
  Additional Info:   Long Draws;  Two Oral Glucose Tolerance Tests performed during study
  Compensation:   contact study center for information

Diabetes Type II Currently taking Actos or Avandia

  Study Medication:   Oral Pill
  Inclusion Criteria:   Males and Females;  Age 18-80
  Study Length:   approximately 28 weeks
  Compensation:   contact study center

Diabetes Type II 

  Study Medication:   Oral Pill
  Inclusion Criteria:   Males and Females;  Age 18-75; either diet controlled or taking Metformin
  Study Length:   59 weeks / 16 visits
  Compensation:   $995.00

return to top
home    current research    study opportunities    healthy living    about dgd research    contact    site map
Copyright © 2008.    dgd Research, Inc.   All rights reserved. web site design by monkee-boy | austin, texas